Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy.

Smoking cessation attempts are often complicated by dysphoria/depression, weight gain, craving, and other nicotine withdrawal symptoms. Fluoxetine's antidepressant and anorectant properties, along with its capacity to attenuate compulsive behavior, suggest that this medication might facilitate smoking cessation treatment. We examined the effect of fluoxetine on smoking cessation in the context of a program that included group cognitive-behavioral therapy (six weeks) and transdermal nicotine patch(ten weeks). In a double-blind randomized trial of fluoxetine for smoking cessation, 150 daily smokers were assigned to placebo (n=48), 20 mg (n=51), or 40 mg fluoxetine (n=51). Fluoxetine did not significantly improve smoking cessation rates, either for those with or without major depressive disorder(MDD)histories or elevated current depression. Our results suggest that fluoxetine may moderate withdrawal symptoms, even if that was not manifested in improved smoking cessation rates. Our results, however, clearly favor the use of fluoxetine if weight gain is a major clinical obstacle to smoking cessation.

[1]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[2]  S. Tomkins,et al.  Psychological model for smoking behavior. , 1966, American journal of public health and the nation's health.

[3]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[4]  K. Fagerström,et al.  Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. , 1978, Addictive behaviors.

[5]  D Adkins,et al.  Predictors of outcome and recidivism in smoking cessation treatment. , 1978, Addictive behaviors.

[6]  Waal-Manning Hj,et al.  Smoking habit and psychometric scores: a community study. , 1978 .

[7]  Saul Shiffman,et al.  Relapse following smoking cessation: a situational analysis. , 1982, Journal of consulting and clinical psychology.

[8]  J R Hughes,et al.  Prevalence of smoking among psychiatric outpatients. , 1986, The American journal of psychiatry.

[9]  D. Hatsukami,et al.  Signs and symptoms of tobacco withdrawal. , 1986, Archives of general psychiatry.

[10]  G. Enas,et al.  Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub). , 1989, International journal of obesity.

[11]  E. Perez-stable,et al.  Depressive symptoms and cigarette smoking among Latinos in San Francisco. , 1990, American journal of public health.

[12]  J. Helzer,et al.  Smoking, smoking cessation, and major depression. , 1990, JAMA.

[13]  J. Matloff,et al.  Influence of negative affect on smoking cessation treatment outcome: a pilot study. , 1990, British journal of addiction.

[14]  L. Covey,et al.  Depressive mood, the single-parent home, and adolescent cigarette smoking. , 1990, American journal of public health.

[15]  N. Breslau,et al.  Nicotine dependence, major depression, and anxiety in young adults. , 1991, Archives of general psychiatry.

[16]  S. Tiffany,et al.  The development and initial validation of a questionnaire on smoking urges. , 1991, British journal of addiction.

[17]  J. Hughes.  Tobacco withdrawal in self-quitters. , 1992, Journal of consulting and clinical psychology.

[18]  A. Glassman.  Cigarette smoking: implications for psychiatric illness. , 1993, The American journal of psychiatry.

[19]  Nicotine, negative affect, and depression. , 1993 .

[20]  A. Winston,et al.  Long-term treatment of double depression: A preliminary study with serotonergic antidepressants , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[21]  A. Ravindran,et al.  Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder. , 1994, Psychopharmacology bulletin.

[22]  Cognitive-Behavioral Intervention Increases Abstinence Rates for Depressive-History Smokers. , 1994 .

[23]  Fluoxetine in the Treatment of Premenstrual Dysphoria , 1995 .

[24]  A. Glassman,et al.  Mood, major depression, and fluoxetine response in cigarette smokers. , 1995, The American journal of psychiatry.

[25]  Darrell R. Schroeder,et al.  A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation , 1997 .

[26]  S. Hall,et al.  Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. , 1998, Archives of general psychiatry.

[27]  C. Patten,et al.  Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism∗ , 1999, British Journal of Psychiatry.

[28]  U. Bjornsdottir,et al.  The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial. , 1999, Addiction.

[29]  B. Spring,et al.  Antidepressant pharmacotherapy helps some cigarette smokers more than others. , 1999, Journal of consulting and clinical psychology.

[30]  L. Stead,et al.  Anxiolytics and antidepressants for smoking cessation. , 2000, The Cochrane database of systematic reviews.

[31]  J. Gault,et al.  Smoking and mental illness , 2001, Pharmacology Biochemistry and Behavior.

[32]  Patterns of change in depressive symptoms during smoking cessation: who's at risk for relapse? , 2002 .

[33]  D. Hedeker,et al.  Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment. , 2002, Journal of consulting and clinical psychology.

[34]  M. Mayo,et al.  Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. , 2002, JAMA.

[35]  J. Prochaska,et al.  Self-efficacy and the stages of self-change of smoking , 1985, Cognitive Therapy and Research.